Core Laboratories Inc. (CLB)
NYSE: CLB · Real-Time Price · USD
11.85
-0.02 (-0.17%)
May 16, 2025, 4:00 PM - Market closed
Core Laboratories Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Core Laboratories stock ranges from a low of $13 to a high of $17. The average analyst price target of $15 forecasts a 26.58% increase in the stock price over the next year.
Price Target: $15.00 (+26.58%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Core Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 2 | 2 | 3 | 3 | 3 |
Sell | 1 | 1 | 1 | 1 | 1 | 1 |
Strong Sell | 1 | 1 | 1 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Citigroup | Citigroup | Hold Maintains $16 → $13 | Hold | Maintains | $16 → $13 | +9.70% | May 13, 2025 |
Stifel | Stifel | Hold Maintains $19 → $15 | Hold | Maintains | $19 → $15 | +26.58% | Apr 15, 2025 |
Citigroup | Citigroup | Strong Sell → Hold Upgrades $15 → $16 | Strong Sell → Hold | Upgrades | $15 → $16 | +35.02% | Mar 12, 2025 |
Citigroup | Citigroup | Strong Sell Maintains $14 → $15 | Strong Sell | Maintains | $14 → $15 | +26.58% | Feb 20, 2025 |
Citigroup | Citigroup | Strong Sell Maintains $15 → $14 | Strong Sell | Maintains | $15 → $14 | +18.14% | Oct 31, 2024 |
Financial Forecast
Revenue This Year
528.62M
from 523.85M
Increased by 0.91%
Revenue Next Year
551.22M
from 528.62M
Increased by 4.28%
EPS This Year
0.82
from 0.66
Increased by 24.54%
EPS Next Year
0.97
from 0.82
Increased by 18.31%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 561.6M | 596.7M | 623.7M | ||
Avg | 528.6M | 551.2M | 599.9M | ||
Low | 496.2M | 517.7M | 582.1M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 7.2% | 12.9% | 13.1% | ||
Avg | 0.9% | 4.3% | 8.8% | ||
Low | -5.3% | -2.1% | 5.6% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.99 | 1.14 | 1.20 | ||
Avg | 0.82 | 0.97 | 1.15 | ||
Low | 0.62 | 0.84 | 1.11 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 49.5% | 38.3% | 23.7% | ||
Avg | 24.5% | 18.3% | 18.2% | ||
Low | -6.5% | 2.5% | 13.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.